Sign in
CompletedNo phase

Dexmedetomidine Versus Midazolam for Peribulbar Block

Key facts

Who runs it
Suez Canal University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
50 people enrolled
Started
1 Dec 2023
Ended
30 Sept 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Dexmedetomidine as an adjuvant to local anesthesia for peribulbar block
  • Midazolam as an adjuvant to local anesthesia for peribulbar block
Record updated
30 April 2025

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Clinical diagnosis of cataract Disease
  • Scheduled for cataract surgery
  • American Society of Anesthesiologists physical status I or II

Who cannot take part

  • History of allergy to any of the study medications
  • Had severe cardiac disease
  • Had chronic obstructive lung disease
  • Had a history of sleep apnea
  • Had impaired mental status
  • Had coagulation abnormalities
  • Refused to participate

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

50 patients of both sexes, ages 18 to 75, who were scheduled for cataract surgery and had physical status I or II according to the American Society of Anesthesiologists were included in this study.

Read full original descriptionShow less

After induction of general anesthesia, all patients received peribulbar block. In group A (midazolam group), 25 patients received midazolam. In group B (dexmedetomidine group), 25 patients received dexmedetomidine.

The 2 groups in the trial

  • peribulbar block 1Existing treatment, for comparison

    Patients who were scheduled for cataract surgery under peribulbar block.

    Treatment: Dexmedetomidine as an adjuvant to local anesthesia for peribulbar block

  • peribulbar block 2Existing treatment, for comparison

    Patients who were scheduled for cataract surgery under peribulbar block.

    Treatment: Midazolam as an adjuvant to local anesthesia for peribulbar block

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Dexmedetomidine Versus Midazolam as an Adjuvant to Local Anesthetic Mixture (Bupivacaine, Lidocaine, and Hyaluronidase) for Peribulbar Block During Cataract Surgery: A Randomized Controlled Trial
Record updated
30 April 2025